MetaCap

Climb Bio Earnings

NASDAQ: CLYMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.00+0.14 (+1.29%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.19

Climb Bio earnings summary

Climb Bio is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.19.

Summary generated from market data by MetaCap's automated system. Methodology

Related